Compare · HIMS vs TDOC
HIMS vs TDOC
Side-by-side comparison of Hims & Hers Health Inc. (HIMS) and Teladoc Health Inc. (TDOC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HIMS and TDOC operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 6.3x TDOC ($1.08B).
- Over the past year, HIMS is down 43.6% and TDOC is down 33.4% - TDOC leads by 10.2 points.
- HIMS has been more active in the news (10 items in the past 4 weeks vs 6 for TDOC).
- Both have 25 recent analyst ratings on file.
- Company
- Hims & Hers Health Inc.
- Teladoc Health Inc.
- Price
- $28.05-4.54%
- $5.68-4.78%
- Market cap
- $6.85B
- $1.08B
- 1M return
- +0.70%
- -9.55%
- 1Y return
- -43.64%
- -33.41%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- 2015
- News (4w)
- 10
- 6
- Recent ratings
- 25
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Teladoc Health Inc.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services. It serves health employers, health plans, hospitals, health systems, and insurance and financial services companies. The company offers its products and services under the Teladoc, Livongo, Advance Medical, Best Doctors, BetterHelp, and HealthiestYou brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York.
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)
Latest TDOC
- Teladoc Health to Announce Third Quarter 2026 Financial Results
- SEC Form SCHEDULE 13G filed by Teladoc Health Inc.
- Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery
- SEC Form 4 filed by Teladoc Health Inc.
- Teladoc Health Inc. filed SEC Form 8-K: Leadership Update
- Teladoc Health Announces Chief Legal Officer Transition
- CHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 42,802 shares and sold $108,682 worth of shares (17,805 units at $6.10), increasing direct ownership by 6% to 465,535 units (SEC Form 4) to cover taxes
- SEC Form 144 filed by Teladoc Health Inc.
- Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- President, International Nueno Carlos converted options into 13,273 shares and sold $39,066 worth of shares (6,200 units at $6.30), increasing direct ownership by 12% to 64,744 units (SEC Form 4) to cover withholding tax